Dr. Joshua Jude Sacha, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 56th Medical Group Allergy/immunizations Clinic, 7219 North Litchfield Road, Luke Afb, AZ 85309 Phone: 623-856-7420 Fax: 602-429-8356 |
Kara Elizabeth Brusher, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-2273 |
Mark Garrett Rieker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7219 N Litchfield Rd, 56th Medical Group, Luke Afb, AZ 85309 Phone: 623-856-4396 |
Dr. Reba Ray, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-6027 |
Nhien Pho, Pediatrics Medicare: Medicare Enrolled Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 618-256-7018 |
Dr. Tiffany Rene Simpson, D.O Pediatrics Medicare: Medicare Enrolled Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-7982 |
News Archive
Pediatric researchers analyzing DNA variations in type 1 diabetes and inflammatory bowel disease have found a complex interplay of genes. Some genes have opposing effects, raising the risk of one disease while protecting against the other. In other cases, a gene variant may act in the same direction, raising the risk for both diseases.
What do we really know about the relationship between the experience of pain and risk of developing opioid use disorder? Results from a recent study - the first to directly address this question - show that people with moderate or more severe pain had a 41 percent higher risk of developing prescription opioid use disorders than those without, independent of other demographic and clinical factors.
Hologic, Inc., a leading women's healthcare company, today announced that final data analysis from the first large-scale independent evaluation of clinical performance of Cervista HPV HR compared to Hybrid Capture 2, were presented in Montreal, Canada, at the 26th International Papillomavirus Conference. Cervista HPV HR is a diagnostic test for the detection of 14 high-risk human papillomavirus types.
Savient Pharmaceuticals, Inc. announced it has priced $200 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes") pursuant to an automatically effective registration statement filed with the Securities and Exchange Commission on January 31, 2011. In addition, Savient has granted the underwriters an option to purchase up to an additional $30 million aggregate principal amount of Notes, solely to cover over-allotments.
A mechanism which can lead to hay fever and other allergic reactions, by preventing the immune system from regulating itself properly, has been discovered by scientists.
› Verified 3 days ago